In aggregate, our data indicate that the HK-fbp1 strain has the potential to be a suitable prophylactic vaccine candidate against invasive fungal infections and, also, a potential therapeutic agent for early-stage cryptococcosis. This evidence concerns the gene FBP1 and fungal infectious disease.